Group One Trading’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Group One Trading’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-445	Closed	-$311	–	8445
2023 Q1	$311	Sell	445 -127	-22%	-$117	﹤0.01%	6958
2022 Q4	$515	Buy	+572	New	+$1.66K	﹤0.01%	6945

Group One Trading's STSA Position: Q2 2023 in Review

Group One Trading sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 445 shares — an estimated $311 sold.

Group One Trading first reported a position in STSA in Q4 2022 and held it in 2 quarters. The position peaked at $515 in Q4 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Group One Trading reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 445 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $311.
Group One Trading first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Group One Trading's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $515 in Q4 2022.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.